Prochloraz

Prochloraz

SCHEMBL45661

CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1.Cc1cccc(CNc2cc(-c3cc(N4CCCCC4)ccc3[N+](=O)[O-])ncn2)c1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.49
CYP1A2 P05177 10/20 0.38
CYP2C19 P33261 10/20 0.38
CYP3A4 P08684 9/20 0.38
CYP2D6 P10635 7/20 0.38
TSHR P16473 4/20 0.38
CLK4 Q9HAZ1 4/20 0.38
ALDH1A1 P00352 7/20 0.34
HPGD P15428 4/20 0.34
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 4/20 0.34
MAPK1 P28482 4/20 0.34
LMNA P02545 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
ALOX15 P16050 1/20 0.34
MAPT P10636 9/20 0.33
CDC7 O00311 1/20 0.33
ROCK2 O75116 1/20 0.33
PIM1 P11309 1/20 0.33
PRKACA P17612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL46429 0.78 CYP1A2 (0.53) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
Prochloraz SCHEMBL3638126 0.73 AHR (0.94) AHRKDM4EMAPK1LMNATDP1
Prochloraz SCHEMBL7381517 0.72 AHR (0.85) AHRALDH1A1KDM4EMAPK1LMNA
Prochloraz SCHEMBL11376321 0.72 AHR (0.88) AHRCYP3A4TSHRALDH1A1KDM4E
Prochloraz SCHEMBL11853137 0.71 AHR (0.64) AHRALDH1A1KDM4EMAPK1LMNA
Prochloraz SCHEMBL22242 0.70 AHR (1.00) AHRKDM4EMAPK1LMNATDP1
Prochloraz SCHEMBL34675 0.70 AHR (1.00) AHRKDM4EMAPK1LMNATDP1
Prochloraz SCHEMBL6620360 0.70 AHR (0.69) AHRCYP3A4ALDH1A1HPGDKDM4E
Prochloraz SCHEMBL11375792 0.70 AHR (0.98) AHRKDM4EMAPK1LMNATDP1
Prochloraz SCHEMBL5454581 0.70 AHR (0.98) AHRKDM4EMAPK1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140023611-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2014-01-23 US disclosed
EP-2591354-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT Ardelyx, Inc. (US) 2013-05-15 EP disclosed
EP-2590656-A2 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT Ardelyx, Inc. (US) 2013-05-15 EP disclosed
WO-2012054110-A2 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-04-26 WO disclosed
WO-2012006475-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140023611-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC10A2, SLC34A2, SLC34A3 AHR 4545/4885CYP1A2 2901/4885CYP2C19 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.